Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn's disease and ulcerative colitis.

Anna Luisa BatheEirini MavropoulouNicolae-Catalin MechieGolo PetzoldVolker EllenriederSteffen KunschAhmad Amanzada

Published in: PloS one (2019)

Measurement of FC may alter physician's clinical decision-making in IBD patients beside other clinical and diagnostic parameters. Further prospective and survey studies are warranted to evaluate the influence of FC measurement in the daily clinical decision-making.

Keyphrases

decision making
end stage renal disease
emergency department
primary care
chronic kidney disease
ejection fraction
systemic lupus erythematosus
newly diagnosed